QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Avanos Medical (AVNS) Competitors

$19.58
+0.07 (+0.36%)
(As of 02/22/2024 ET)

AVNS vs. ESTA, ZJYL, SMTI, ENOV, RAPT, OLMA, SIBN, CRGX, IGMS, and ETNB

Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include Establishment Labs (ESTA), Jin Medical International (ZJYL), Sanara MedTech (SMTI), Enovis (ENOV), RAPT Therapeutics (RAPT), Olema Pharmaceuticals (OLMA), SI-BONE (SIBN), CARGO Therapeutics (CRGX), IGM Biosciences (IGMS), and 89bio (ETNB). These companies are all part of the "medical" sector.

Avanos Medical vs.

Establishment Labs (NASDAQ:ESTA) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings.

In the previous week, Avanos Medical had 8 more articles in the media than Establishment Labs. MarketBeat recorded 20 mentions for Avanos Medical and 12 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.16 beat Avanos Medical's score of 0.13 indicating that Avanos Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
3 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avanos Medical
4 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Avanos Medical has higher revenue and earnings than Establishment Labs. Avanos Medical is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$161.70M5.87-$75.21M-$2.80-13.13
Avanos Medical$673.30M1.35$50.50M-$1.32-14.83

Establishment Labs has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.

78.6% of Establishment Labs shares are held by institutional investors. Comparatively, 93.8% of Avanos Medical shares are held by institutional investors. 12.6% of Establishment Labs shares are held by company insiders. Comparatively, 2.9% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Establishment Labs currently has a consensus target price of $67.67, suggesting a potential upside of 84.08%. Avanos Medical has a consensus target price of $31.00, suggesting a potential upside of 58.32%. Given Avanos Medical's stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Avanos Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Avanos Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Avanos Medical has a net margin of -8.76% compared to Avanos Medical's net margin of -40.32%. Establishment Labs' return on equity of 4.25% beat Avanos Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-40.32% -467.62% -29.31%
Avanos Medical -8.76%4.25%3.11%

Establishment Labs received 28 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 61.58% of users gave Establishment Labs an outperform vote while only 55.10% of users gave Avanos Medical an outperform vote.

CompanyUnderperformOutperform
Establishment LabsOutperform Votes
109
61.58%
Underperform Votes
68
38.42%
Avanos MedicalOutperform Votes
81
55.10%
Underperform Votes
66
44.90%

Summary

Establishment Labs and Avanos Medical tied by winning 9 of the 18 factors compared between the two stocks.


Get Avanos Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVNS vs. The Competition

MetricAvanos MedicalSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$909.02M$5.70B$5.15B$17.39B
Dividend YieldN/A1.07%2.91%3.57%
P/E Ratio-14.8320.00127.6824.83
Price / Sales1.3553.113,009.325.70
Price / Cash9.6416.8789.9717.89
Price / Book0.743.064.306.35
Net Income$50.50M$108.19M$112.86M$869.26M
7 Day Performance-0.56%-1.19%1.03%-1.00%
1 Month Performance2.35%2.16%6.46%1.82%
1 Year Performance-32.78%-15.69%8.15%76.54%

Avanos Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESTA
Establishment Labs
2.7862 of 5 stars
$37.25
-5.0%
$67.67
+81.7%
-48.4%$961.42M$161.70M-13.30958Upcoming Earnings
News Coverage
ZJYL
Jin Medical International
0 of 5 stars
$8.50
+2.3%
N/AN/A$1.32BN/A0.00269Gap Up
SMTI
Sanara MedTech
1.4187 of 5 stars
$35.12
-7.4%
$49.00
+39.5%
-9.4%$299.93M$45.84M-35.12101News Coverage
Gap Down
ENOV
Enovis
2.4508 of 5 stars
$59.77
-1.5%
$71.86
+20.2%
-2.1%$3.26B$1.56B-43.636,800Earnings Report
News Coverage
Gap Up
RAPT
RAPT Therapeutics
3.9683 of 5 stars
$24.99
-5.5%
$36.33
+45.4%
-64.9%$859.66M$1.53M-8.68129Analyst Downgrade
News Coverage
Gap Down
OLMA
Olema Pharmaceuticals
3.4832 of 5 stars
$15.47
-6.9%
$21.00
+35.7%
+233.4%$852.40MN/A-6.6770Positive News
Gap Down
SIBN
SI-BONE
3.7946 of 5 stars
$20.88
-3.2%
$26.33
+26.1%
+23.0%$845.64M$106.41M-17.55357Upcoming Earnings
Gap Down
CRGX
CARGO Therapeutics
0.3532 of 5 stars
$21.41
-3.7%
$28.33
+32.3%
N/A$882.31MN/A0.0042News Coverage
IGMS
IGM Biosciences
4.2636 of 5 stars
$15.25
-12.0%
$17.80
+16.7%
-35.7%$890.45M$1.07M-3.06290Gap Down
ETNB
89bio
0.8888 of 5 stars
$8.85
-5.7%
$31.56
+256.6%
-24.7%$824.91MN/A-4.4545Gap Down

Related Companies and Tools

This page (NYSE:AVNS) was last updated on 2/22/2024 by MarketBeat.com Staff